Management of Chronic Hepatitis B Patients: Efficacy & Limitation of Nucleos(T)Ide Analogues (Commentary) (Report)

Management of Chronic Hepatitis B Patients: Efficacy & Limitation of Nucleos(T)Ide Analogues (Commentary) (Report)

Hepatitis B virus (HBV) causes a spectrum of liver diseases including acute hepatitis, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. HBV contains a circular, partially double-stranded DNA genome of 3.2 kb. This genome includes 4 partly overlapping open reading frames. One of these is the polymerase gene that encodes for the polymerase protein including the reverse transcriptase (RT) region. In the process of HBV replication, the pregenomic RNA, which is transcribed from covalently closed circular DNA (cccDNA), is reverse-transcribed by the polymerase protein of HBV. This step is mainly targeted by nucleos(t)ide analogues such as lamivudine, adefovir, entecavir, tenofovir, and telbivudine. Oral administration of these drugs results in virological, biochemical, and histological improvement in most patients (1), but the effect is often transient due to the emergence of drug-resistant mutants of HBV. In this issue, Kumar et al (2) performed a randomized pilot study to compare lamivudine and adefovir in terms of the HBV kinetics. To our knowledge, this is the first report of a randomized study comparing these drugs, and hence valuable. Based on several previous studies, it was thought that adefovir has weaker suppressive effect on serum HBV DNA than other nucleos(t)ide analogues including lamivudine (3,4): the virological response (undetectable HBV DNA) rate of adefovir at 1 year was 21 per cent, and that of lamivudine was 39-44 per cent. However, this 24-wk study showed no significant difference in virological, biological, and histological responses between adefovir and lamivudine. A recent meta-analysis, which compared 48-52-wk outcomes of several antiviral drugs to HBV, demonstrated that there was no significant difference in outcomes between adefovir and lamivudine in both HBeAg-positive and HBeAg-negative patients (5). Therefore, the results of Kumar et al (2) seem to be reasonable. The sample size however is small and the treatment duration was short, as they described. A larger samples is needed to reach a conclusion, and analyses should be performed in view of the HBeAg status and HBV genotypes, which are known to affect the efficacy of anti-viral drugs (6).

Management of Chronic Hepatitis B Patients: Efficacy & Limitation of Nucleos(T)Ide Analogues (Commentary) (Report)



Here is Download Link

Management Of Chronic Viral Hepatitis Second Edition


Management Of Chronic Viral Hepatitis Second Edition Read Online Download

Author by : Stuart Gordon
Languange Used : en
Release Date : 2004-12-29
Publisher by : CRC Press






Hepatitis B Virus And Liver Disease


Hepatitis B Virus And Liver Disease Read Online Download

Author by : Jia-Horng Kao
Languange Used : en
Release Date : 2018-01-12
Publisher by : Springer






A National Strategy For The Elimination Of Hepatitis B And C


A National Strategy For The Elimination Of Hepatitis B And C Read Online Download

Author by : National Academies of Sciences, Engineering, and Medicine
Languange Used : en
Release Date : 2017-06-30
Publisher by : National Academies Press






Antiviral Drug Resistance


Antiviral Drug Resistance Read Online Download

Author by : Douglas D. Richman
Languange Used : en
Release Date : 1996-12-02
Publisher by : Wiley






Primary Care Management Of Hepatitis B


Primary Care Management Of Hepatitis B Read Online Download

Author by : Public Health Agency of Canada
Languange Used : en
Release Date : 2013
Publisher by :






Eliminating The Public Health Problem Of Hepatitis B And C In The United States


Eliminating The Public Health Problem Of Hepatitis B And C In The United States Read Online Download

Author by : National Academies of Sciences, Engineering, and Medicine
Languange Used : en
Release Date : 2016-06-01
Publisher by : National Academies Press






Acute Exacerbation Of Chronic Hepatitis B


Acute Exacerbation Of Chronic Hepatitis B Read Online Download

Author by : Qin Ning
Languange Used : en
Release Date :
Publisher by : Springer






Viral Hepatitis In Children


Viral Hepatitis In Children Read Online Download

Author by : Maureen M. Jonas
Languange Used : en
Release Date : 2010-09-02
Publisher by : Springer Science & Business Media






Hepatitis B And C


Hepatitis B And C Read Online Download

Author by : Thierry Poynard
Languange Used : en
Release Date : 2004-08-25
Publisher by : CRC Press






Antiviral Agents And Viral Diseases Of Man


Antiviral Agents And Viral Diseases Of Man Read Online Download

Author by : George J. Galasso
Languange Used : en
Release Date : 1990-01-01
Publisher by : Lippincott Williams & Wilkins






Leave a Reply

Your email address will not be published. Required fields are marked *